China E-Pharmacy Market Overview, 2028

China has witnessed a significant increase in internet penetration, with a large population having access to smartphones and high-speed internet connections. This widespread internet usage provides a solid foundation for the growth of e-pharmacy platforms and their services. Furthermore, as the Chinese population becomes more health-conscious and disposable incomes rise, there has been a corresponding increase in healthcare expenditure. Consumers are willing to spend more on healthcare products and services, including medicines purchased through e-pharmacy platforms. Moreover, China is facing the challenges associated with an ageing population and a rising burden of chronic diseases. E-pharmacy platforms provide a means to manage these healthcare needs by offering a wide range of medications, chronic disease management services, and health monitoring devices. In addition, China has a significant urban-rural healthcare divide, with rural areas facing limited access to healthcare services. E-pharmacy platforms play a crucial role in bridging this gap by providing online access to medicines and healthcare services, thereby addressing the healthcare disparities between urban and rural regions. According to the research report "China E-Pharmacy Market Overview, 2028," published by Bonafide Research, the China E-Pharmacy market was valued at more than USD 9 Billion in 2022. E-pharmacy platforms in China are increasingly focusing on sustainability and green initiatives. They are promoting eco-friendly packaging, reducing single-use plastic, and implementing recycling programs to minimize their environmental impact. Furthermore, e-pharmacy platforms in China are increasingly offering online prescription services. Consumers can upload their prescriptions digitally, consult with healthcare professionals remotely, and receive e-prescriptions, making it more convenient to refill medications and access healthcare services. Moreover, some e-pharmacy platforms offer virtual consultations with licensed pharmacists. Users can seek professional advice and guidance on medication usage, potential drug interactions, and general health-related concerns. In addition, e-pharmacy platforms in China are leveraging big data analytics to gain insights into consumer behavior, medication usage patterns, and market trends. This data-driven approach helps platforms optimize their product offerings, marketing strategies, and personalized recommendations.

China has a population affected by diabetes, making diabetes care products a crucial category in the e-pharmacy market. These products include blood glucose monitoring devices, test strips, insulin, oral medications, diabetic-friendly foods, dietary supplements, and diabetic foot care products. E-pharmacy platforms in China provide a convenient way for individuals with diabetes to access these products, monitor their blood sugar levels, and manage their condition effectively. Furthermore, naturopathy is gaining popularity in China as an alternative healthcare approach that focuses on natural therapies and remedies to support the body's healing mechanisms. Naturopathic products available through e-pharmacy platforms include herbal supplements, traditional Chinese medicine formulations, dietary and nutritional supplements, and natural skincare and personal care products. Chinese consumers are increasingly interested in naturopathy for promoting overall wellness and addressing specific health concerns. The Drug Administration Law of the People's Republic of China serves as the primary legislation governing the pharmaceutical industry, including e-pharmacy. It sets standards for drug production, distribution, and sales, emphasizing the importance of product quality, safety, and authenticity. Furthermore, the Internet Drug Information Service Management Measures issued by the China Food and Drug Administration (CFDA) outline specific requirements for internet-based drug information services, including E-Pharmacy platforms. They cover aspects such as licensing, qualifications, information accuracy, data security, and advertising regulations. Moreover, the Chinese government has established regulations for cross-border e-pharmacy imports. Platforms must comply with customs procedures, import regulations, and product registration requirements to ensure the safety and quality of imported drugs and healthcare products. In addition, the Chinese government has been actively supporting the development of e-pharmacy. It has implemented policies to encourage the integration of online and offline healthcare services, promote the use of digital technology, and foster innovation in the sector. Considered in this report • Geography: China • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Ask an Expert

Manmayi Raval

Research Consultant

Aspects covered in this report • China E-Pharmacy market with its value and forecast along with its segments • On-going trends and developments • Top profiled companies • Strategic recommendation By Drug Type • Prescription drug • Over-the-counter drug By Product Type Channel • Skin Care (Skin diseases & skin injuries) • Allergy & food intolerance, Stomach, Intestines & Digestion • Diabetes Care • Heart care, circulation & veins, BP, cholesterol • Orthopedic (muscles, bones, joints) • Urology (Bladder, Kidney & Prostate) • Animal pharmacy • Naturopathy • ENT (Eyes, ears, Tooth & Mouth) • Cold flu • vitamins & minerals • Cosmetics • Painkiller • Others (gynec, Calm down, sleep & stress, sexuality, Lose weight, Diet & Lifestyle, Self-tests & everyday aids, smoking cessation)

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and listing out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, annual report of companies, analyzing the government generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducted trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers in regional aspects, tier aspects, age group, and gender. Once we have primary data with us we have started verifying the details obtained from secondary sources. Intended audience This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to ready to E-Pharmacy industry, government bodies and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.